Clinical Trial Update: Auto-immunity in Lupus Patients After Influenza Vaccine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing auto-immunity in systemic lupus erythematosus patients following influenza vaccination has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 2 | Status: COMPLETED